Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,581,873
  • Shares Outstanding, K 355,081
  • Annual Sales, $ 5,101 M
  • Annual Income, $ -360,000 K
  • EBIT $ 371 M
  • EBITDA $ 810 M
  • 60-Month Beta 0.58
  • Price/Sales 1.13
  • Price/Cash Flow 9.60
  • Price/Book 0.87
  • Price/Earnings ttm 32.34
  • Earnings Per Share ttm 0.50
  • Most Recent Earnings $0.32 on 02/18/26
  • Next Earnings Date 04/29/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 64.87% (+13.16%)
  • Historical Volatility 34.60%
  • IV Percentile 61%
  • IV Rank 19.67%
  • IV High 187.31% on 11/19/25
  • IV Low 34.89% on 12/23/25
  • Expected Move (DTE 27) 1.19 (7.57%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 236
  • Volume Avg (30-Day) 320
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 4,033
  • Open Int (30-Day) 3,159
  • Expected Range 14.53 to 16.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.07
  • Number of Estimates 6
  • High Estimate 0.14
  • Low Estimate 0.02
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.58 +0.90%
on 03/20/26
18.92 -16.89%
on 02/25/26
-2.22 (-12.37%)
since 02/20/26
3-Month
15.58 +0.90%
on 03/20/26
18.92 -16.89%
on 02/25/26
-1.26 (-7.42%)
since 12/19/25
52-Week
10.45 +50.43%
on 04/30/25
18.92 -16.89%
on 02/25/26
-0.03 (-0.19%)
since 03/20/25

Most Recent Stories

More News
Bausch + Lomb Launches R&D “Teach-in” Webinar Series

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the first event in an R&D “Teach-in” webinar series...

BLCO.TO : 22.14 (+0.05%)
BLCO : 15.72 (-2.78%)
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

UHS : 185.82 (-0.75%)
IART : 8.94 (+0.45%)
GEHC : 69.65 (-1.04%)
BLCO : 15.72 (-2.78%)
ICUI : 125.36 (-1.00%)
2 Profitable Stocks Worth Investigating and 1 We Ignore

2 Profitable Stocks Worth Investigating and 1 We Ignore

FRSH : 8.03 (-0.86%)
AZZ : 118.98 (-1.88%)
BLCO : 15.72 (-2.78%)
5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

BLCO : 15.72 (-2.78%)
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®

Global review highlights increasing prevalence of noninfectious ocular redness due to digital eye strain, dry eye disease, allergies and environmental exposures LUMIFY redness reliever...

BLCO.TO : 22.14 (+0.05%)
BLCO : 15.72 (-2.78%)
3 Small-Cap Stocks We Steer Clear Of

3 Small-Cap Stocks We Steer Clear Of

BLCO : 15.72 (-2.78%)
NVAX : 9.62 (-1.23%)
VNT : 35.20 (-0.37%)
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

BLCO : 15.72 (-2.78%)
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue

Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue

BLCO : 15.72 (-2.78%)
Bausch + Lomb: Q4 Earnings Snapshot

Bausch + Lomb: Q4 Earnings Snapshot

BLCO : 15.72 (-2.78%)
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

Delivered meaningful EBITDA margin expansion and operating leverage in the fourth quarter Fourth-Quarter 2025 Financial Results ...

BLCO.TO : 22.14 (+0.05%)
BLCO : 15.72 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 16.87
2nd Resistance Point 16.59
1st Resistance Point 16.15
Last Price 15.72
1st Support Level 15.43
2nd Support Level 15.15
3rd Support Level 14.71

See More

52-Week High 18.92
Last Price 15.72
Fibonacci 61.8% 15.68
Fibonacci 50% 14.68
Fibonacci 38.2% 13.68
52-Week Low 10.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.